Funder
Ministry of Education, Culture, Sports, Science and Technology - Supported Program for the Strategic Research Foundation at Private Universities
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference34 articles.
1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
2. Peterson C. Drug therapy of cancer. Eur J Clin Pharmacol. 2011;67:437–447.
3. Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med. 2011;17:313–319.
4. Matsuda T, Aruga A. Comparison of regulations for the development of oncolytic virus therapy in the United States, the European Union, and Japan. J Regul Sci. 2016;4:1–9.
5. Shibata S, Uemura R, Chiba K, et al. A comprehensive analysis of factors that contribute to conditional approval and all-case surveillance designations that subsequently lead to shortening of review times in Japan. J Regul Sci. 2016;4:1–9.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献